LAROSA JOSEPH J — SEC Form 4 filings
SEC reporting owner CIK 1238303. 12 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-09 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 6,731 shares, $6,795,119 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 1,866 shares @ $1,088.95 ($2,031,981) in REGENERON PHARMACEUTICALS, INC., filed 2024-07-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP General Counsel and Secret | 12 | — | 5 legs · 6,731 sh · $6,795,119 | 17 |
Form 4 filings — LAROSA JOSEPH J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 12,282 @ $381.92 · Tax withholding (F): 9,019 @ $830.15 · Option exercise (M): 12,282 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,476 @ $0 · Tax withholding (F): 1,396 @ $712.94 · Grant/award (A): 12,210 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 14,450 @ $555.67 · Tax withholding (F): 12,686 @ $736.77 · Option exercise (M): 14,450 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 702 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,332 @ $0 · Tax withholding (F): 492 @ $787 · Grant/award (A): 8,981 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,866 @ $1,088.95 | EDGAR |
| 2024-06-25 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 14,450 @ $555.67 · Tax withholding (F): 11,084 @ $1,060.13 · Option exercise (M): 14,450 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,608 @ $0 | EDGAR |
| 2024-05-22 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,865 @ $994.90 | EDGAR |
| 2024-02-28 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $990 | EDGAR |
| 2024-02-26 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $967.65 | EDGAR |
| 2024-02-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,000 @ $950 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1238303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →